CClinicalTrials.gg
Enrolling by invitationNCT07622849Updated Jun 3, 2026

FMT in Transplant-related Gastrointestinal Mucositis

An observational study in Transplant-related Gastrointestinal Mucositis, sponsored by The First Affiliated Hospital of Soochow University. Enrolling by invitation at 1 site in China. Open to participants aged 15 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by The First Affiliated Hospital of Soochow University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
20
Ages
15 Years to 65 Years
Sex
All
01

Study summary

With the stem cell transplant increasing, patients which effected with transplant-related gastrointestinal mucositis (TRGM) have also increased. To evaluate the safety and efficacy of FMT for TRGM, patients with TRGM were recruited.

02

Conditions studied

  • Transplant-related Gastrointestinal Mucositis
03

In context

Lead sponsor

The First Affiliated Hospital of Soochow University is the lead sponsor of 252 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients who suffered transplant-related gastrointestinal mucositis were recruited, and treated with FMT

Inclusion criteria

  • Transplant-related gastrointestinal mucositis

Exclusion criteria

Exclusion Criteria:

  • age>65; or age\<15;
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
20 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes

Interventions

  • BiologicalFecal Microbiota

    fecal microbiota transplantation

06

What researchers measure

Primary outcomes

  1. aGVHD

    Occurrence time and severity of aGVHD

    Time frame: 2 weeks, 4 weeks, 2 months, 3 months

07

Study locations

1 site
  • Soochow University
    Suzhou, Jiangsu 215006, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07622849
Lead sponsor
The First Affiliated Hospital of Soochow University
Responsible party
Qi Xiao-Fei (professor, The First Affiliated Hospital of Soochow University) — Principal investigator
First posted
Jun 3, 2026
Start date
Mar 1, 2023
Primary completion
Dec 1, 2028 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Jun 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion